|
2025-06-03 |
2025-06-03 |
B
Purchase
|
BIENAIME JEAN JACQUES
Non-Executive Director
|
5,000
+15.9%
9.38
USD 46,900
|
5,000
+15.9%
|
9.38
|
USD 46,900
|
|
|
2025-03-26 |
2025-03-26 |
B
Purchase
|
SIEGALL CLAY B
President and CEO
Executive Director
|
137,100
+20.5%
7.29
USD 999,459
|
137,100
+20.5%
|
7.29
|
USD 999,459
|
|
|
2025-03-26 |
2025-03-25 |
B
Purchase
|
BIENAIME JEAN JACQUES
Non-Executive Director
|
7,800
+33.0%
7.78
USD 60,684
|
7,800
+33.0%
|
7.78
|
USD 60,684
|
|
|
2025-03-25 |
2025-03-24 |
B
Purchase
|
BIENAIME JEAN JACQUES
Non-Executive Director
|
7,000
+42.1%
8.21
USD 57,470
|
7,000
+42.1%
|
8.21
|
USD 57,470
|
|
|
2025-03-25 |
2025-03-24 |
B
Purchase
|
Tsai Philip
Chief Technology Officer
Officer
|
12,300
+58.6%
8.42
USD 103,566
|
12,300
+58.6%
|
8.42
|
USD 103,566
|
|
|
2025-02-03 |
2025-01-31 |
B
Purchase
|
SIEGALL CLAY B
President and CEO
Executive Director
|
150,000
+28.9%
7.75
USD 1,162,500
|
150,000
+28.9%
|
7.75
|
USD 1,162,500
|
|
|
2024-11-25 |
2024-11-22 |
B
Purchase
|
SIEGALL CLAY B
President and CEO
Executive Director
|
33,943
+7.0%
9.78
USD 331,918
|
33,943
+7.0%
|
9.78
|
USD 331,918
|
|
|
2024-11-25 |
2024-11-21 |
B
Purchase
|
SIEGALL CLAY B
President and CEO
Executive Director
|
66,057
+15.7%
9.54
USD 630,263
|
66,057
+15.7%
|
9.54
|
USD 630,263
|
|
|
2024-11-25 |
2024-11-21 |
B
Purchase
|
Lechleider Robert
Chief Medical Officer
Officer
|
15,805
+inf%
9.48
USD 149,800
|
15,805
+inf%
|
9.48
|
USD 149,800
|
|
|
2024-11-25 |
2024-11-21 |
B
Purchase
|
Tsai Philip
Chief Technology Officer
Officer
|
21,000
+inf%
9.43
USD 198,030
|
21,000
+inf%
|
9.43
|
USD 198,030
|
|
|
2024-09-20 |
2024-09-19 |
S
Sale
|
Rosett Max
Chief Financial Officer
Officer
|
14,380
-23.2%
16.01
USD 230,224
|
14,380
-23.2%
|
16.01
|
USD 230,224
|
|
|
2024-08-19 |
2024-08-16 |
B
Purchase
|
BIENAIME JEAN JACQUES
Non-Executive Director
|
7,000
+72.8%
13.94
USD 97,608
|
7,000
+72.8%
|
13.94
|
USD 97,608
|
|
|
2024-08-19 |
2024-08-15 |
S
Sale
|
Higgins Jack
Chief Scientific Officer
Officer
|
3,524
-18.0%
13.93
USD 49,072
|
3,524
-18.0%
|
13.93
|
USD 49,072
|
|
|
2024-05-22 |
2024-05-21 |
B
Purchase
|
BIENAIME JEAN JACQUES
Non-Executive Director
|
2,000
+26.3%
13.57
USD 27,140
|
2,000
+26.3%
|
13.57
|
USD 27,140
|
|
|
2024-05-21 |
2024-05-21 |
B
Purchase
|
SIEGALL CLAY B
President and CEO
Executive Director
|
20,434
+5.1%
13.78
USD 281,548
|
20,434
+5.1%
|
13.78
|
USD 281,548
|
|
|
2024-05-21 |
2024-05-20 |
B
Purchase
|
SIEGALL CLAY B
President and CEO
Executive Director
|
79,566
+24.9%
13.91
USD 1,106,524
|
79,566
+24.9%
|
13.91
|
USD 1,106,524
|
|
|
2023-10-04 |
2023-10-02 |
B
Purchase
|
SIEGALL CLAY B
President and CEO
Executive Director
|
169,204
+112.5%
5.91
USD 999,996
|
169,204
+112.5%
|
5.91
|
USD 999,996
|
|
|
2023-10-04 |
2023-10-02 |
B
Purchase
|
Turner Bruce
Chief Strategy Officer
Officer
|
42,300
+inf%
5.91
USD 249,993
|
42,300
+inf%
|
5.91
|
USD 249,993
|
|
|
2021-09-14 |
2021-09-13 |
B
Purchase
|
RAPP MICHAEL
Non-Executive Director
|
25,962
+14.2%
19.96
USD 518,202
|
25,962
+14.2%
|
19.96
|
USD 518,202
|
|
|
2021-09-13 |
2021-09-10 |
B
Purchase
|
RAPP MICHAEL
Non-Executive Director
|
15,500
+9.3%
17.85
USD 276,675
|
15,500
+9.3%
|
17.85
|
USD 276,675
|
|
